Skip to main navigation
Skip to search
Skip to main content
Fujita Health University Home
English
日本語
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
ChREBP and cancer
Katsumi Iizuka
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'ChREBP and cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Tumor Growth
100%
Neoplasm
50%
Adenosine Triphosphate
25%
Transcription Factors
25%
Statin (Protein)
25%
Liver Cell Carcinoma
25%
Prostate Cancer
25%
Metformin
25%
Primary Tumor
25%
Metastasis
25%
Biochemistry, Genetics and Molecular Biology
Tumor Progression
100%
Transcription
50%
Mesenchymal-Epithelial Transition
50%
Gene Expression
25%
Transcription Factors
25%
Adenosine Triphosphate
25%
Statin
25%
Cell Migration
25%
Lipogenesis
25%
Nucleotide Metabolism
25%
Keyphrases
ChREBP
100%
Tumor Progression
27%
Transcription Activity
18%
Epithelial-mesenchymal Transition
18%
Hepatocellular Carcinoma
9%
Tumor Cells
9%
Therapeutic Potential
9%
Transcription Factor
9%
Statins
9%
Prostate Cancer
9%
Nucleotide Synthesis
9%
New Therapeutics
9%
Primary Tumor
9%
Cell Tumor
9%
Metformin
9%
Cell Migration
9%
Tumor Metastasis
9%
Tumor Proliferation
9%
Lipogenesis
9%
Tumor Dissemination
9%
ATP Consumption
9%
Migration Cell
9%
Lipogenic Gene Expression
9%